Lobbying registration dated 2026-01-26
Registrant: Matthew Gardner
Client: Emergent BioSolutions Canada Inc.
Targeted institutions:
Public Safety Canada (PS)
Finance Canada (FIN)
Royal Canadian Mounted Police (RCMP)
Crown-Indigenous Relations and Northern Affairs Canada (CIRNAC)
Correctional Service of Canada (CSC)
Public Services and Procurement Canada (PSPC)
Veterans Affairs Canada (VAC)
Prime Minister's Office (PMO)
National Defence (DND)
House of Commons
Innovation, Science and Economic Development Canada (ISED)
Indigenous Services Canada (ISC)
Public Health Agency of Canada (PHAC)
Prairies Economic Development Canada (PrairiesCan)
Senate of Canada
Health Canada (HC)
Government funding received:
Lobbying activity details:
Engage Health and National Defence concerning Emergent's Winnipeg facility for the production of medical countermeasures.
To work with government to make NARCAN® (Naloxone HCI) Nasal Spray more widely available across Canada to facilitate immediate treatment to individuals suffering from opioid overdose.
Seek funding support from the Strategic Innovation Fund to expand Emergent's Winnipeg facility.
Discuss changes to take home naloxone program.
Eligibility for Scientific Research and Experimental Development tax incentives.
Engage National Defence, Health, and Global Affairs Canada on national readiness in response to emerging global health threats.
Engage government regarding the need for sustainable manufacturing, procurement and stockpiling of medical countermeasures used to diagnose, prevent, or treat diseases related to chemical, biological, radiological, or nuclear threats.